150 related articles for article (PubMed ID: 29988512)
1. Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites.
Leber MF; Baertsch MA; Anker SC; Henkel L; Singh HM; Bossow S; Engeland CE; Barkley R; Hoyler B; Albert J; Springfeld C; Jäger D; von Kalle C; Ungerechts G
Mol Ther Oncolytics; 2018 Jun; 9():30-40. PubMed ID: 29988512
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
Baertsch MA; Leber MF; Bossow S; Singh M; Engeland CE; Albert J; Grossardt C; Jäger D; von Kalle C; Ungerechts G
Cancer Gene Ther; 2014 Sep; 21(9):373-80. PubMed ID: 25145311
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
Ruiz AJ; Hadac EM; Nace RA; Russell SJ
J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.
Anker SC; Szczeponik MG; Dessila J; Dittus K; Engeland CE; Jäger D; Ungerechts G; Leber MF
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851522
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.
Singh HM; Leber MF; Bossow S; Engeland CE; Dessila J; Grossardt C; Zaoui K; Bell JC; Jäger D; von Kalle C; Ungerechts G
Mol Ther Oncolytics; 2021 Jun; 21():340-355. PubMed ID: 34141871
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and oncolytic viruses.
Ruiz AJ; Russell SJ
Curr Opin Virol; 2015 Aug; 13():40-8. PubMed ID: 25863717
[TBL] [Abstract][Full Text] [Related]
7. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
8. Measles virus as an oncolytic vector platform.
Blechacz B; Russell SJ
Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
[TBL] [Abstract][Full Text] [Related]
10. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy.
Shayestehpour M; Moghim S; Salimi V; Jalilvand S; Yavarian J; Romani B; Mokhtari-Azad T
Virus Res; 2017 Aug; 240():207-214. PubMed ID: 28867494
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-based Regulation of Picornavirus Tropism.
Ruiz AJ; Russell SJ
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287517
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.
Tsetsarkin KA; Liu G; Volkova E; Pletnev AG
mBio; 2017 Apr; 8(2):. PubMed ID: 28420742
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
Lee CY; Rennie PS; Jia WW
Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
[TBL] [Abstract][Full Text] [Related]
14. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
[TBL] [Abstract][Full Text] [Related]
15. Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy.
Xia M; Luo D; Dong J; Zheng M; Meng G; Wu J; Wei J
J Exp Clin Cancer Res; 2019 Sep; 38(1):408. PubMed ID: 31533779
[TBL] [Abstract][Full Text] [Related]
16. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
[TBL] [Abstract][Full Text] [Related]
17. Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.
Kuznetsova I; Arnold T; Aschacher T; Schwager C; Hegedus B; Garay T; Stukova M; Pisareva M; Pleschka S; Bergmann M; Egorov A
Mol Ther Oncolytics; 2017 Dec; 7():37-44. PubMed ID: 29034314
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-regulated viral vectors for gene therapy.
Geisler A; Fechner H
World J Exp Med; 2016 May; 6(2):37-54. PubMed ID: 27226955
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
[TBL] [Abstract][Full Text] [Related]
20. Potential and clinical translation of oncolytic measles viruses.
Robinson S; Galanis E
Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
